Evgen Pharma (GB:TCF) has released an update.
Evgen Pharma has reported a significant change in share ownership, with First Equity Limited acquiring a notable amount of voting rights, raising their total to 5.896849% as of June 3, 2024. This change represents an increase from the previous notification where they held 4.680039% of the voting rights. The update, which indicates a potential shift in control or influence within the company, was officially completed and announced on June 4, 2024.
For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.
